Biotage AB (publ) publishes new Financial Goals
Biotage has two financial goals in its business, an organic sales growth goal of 8 percent and a profitability goal on EBIT- level of 15 percent.
The EBIT-goal is now adjusted up to 20 percent based on the beneficial development of the business. The organic sales growth goal remains unchanged.
The goals are formulated as an average for rolling three-year periods.
This information was submitted for publication, through the agency of the contact persons set out above, at 17:30 CET on November 5, 2018.
Torben Jörgensen, CEO
Tel: +46 707 49 05 84, firstname.lastname@example.org
Biotage offers efficient separation technologies from analysis to industrial-scale and high-quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by public authorities, academic institutions, contract research and contract manufacturing organizations and in the pharmaceutical and food industries, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan, South Korea and India. Biotage has approx. 410 employees and had sales of 748 MSEK in 2017. Biotage is listed on Nasdaq Stockholm. Website: www.biotage.com